ClinicalTrials.Veeva
Menu

Find clinical trials for Lymphoma in Cleveland, OH

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

B-Cell Lymphoma
Leukemia
Non-Hodgkin Lymphoma
Lymphoid Leukemia
Diffuse Large B-Cell Lymphoma
Precursor Cell Lymphoblastic Leukemia-Lymphoma
B-Cell Chronic Lymphocytic Leukemia

Lymphoma trials near Cleveland, OH, USA:

Phase 1 Study of BAFF CAR-T Cells (LMY-920) for Non-Hodgkin Lymphoma

Therapy with chimeric antigen receptor T (CAR-T) cells has demonstrated activity against refractory lymphoma, however not all tumors respond...

Enrolling
Lymphoma, Non-Hodgkin Lymphoma, B-Cell
Drug: BAFF CAR-T

Phase 1

Luminary Therapeutics

Cleveland, Ohio, United States and 1 other location

patients diagnosed with advanced Relapsed/Refractory non-Hodgkin's lymphoma to determine if ARV-393 may be a possible treatment option.ARV-3...

Enrolling
Relapsed/Refractory (R/R) Angioimmunoblastic T-cell Lymphoma (AITL)
Relapsed/Refractory (R/R) Mature B Cell Non Hodgkin Lymphoma (NHL)
Drug: ARV-393

Phase 1

Arvinas
Arvinas

Cleveland, Ohio, United States and 7 other locations

Follicular lymphoma (FL), marginal zone lymphoma (MZL), and mantle cell lymphoma (MCL) are distinct histologic types of B-...

Active, not recruiting
Lymphoma, Non-Hodgkin
Drug: Rituximab
Drug: Lenalidomide

Phase 3

Celgene
Celgene

Cleveland, Ohio, United States and 125 other locations

TrAVeRse is a multicentre, open-label, randomised, Phase II study of AVR in treatment naïve MCL participants. The primary objective will be to assess...

Enrolling
Mantle Cell Lymphoma (MCL)
Drug: Venetoclax
Drug: Rituximab

Phase 2

AstraZeneca
AstraZeneca

Cleveland, Ohio, United States and 47 other locations

This is a global Phase 2, open-label, single-arm, multicohort, multicenter study to evaluate efficacy and safety of JCAR017 in adult subjects with r/...

Active, not recruiting
Lymphoma, Non-Hodgkin
Drug: Fludarabine
Drug: JCAR017

Phase 2

Celgene
Celgene

Cleveland, Ohio, United States and 37 other locations

This trial will study two treatment combinations for classical Hodgkin lymphoma (cHL). This trial will find out if these two treatment combi...

Active, not recruiting
Hodgkin Lymphoma
Drug: doxorubicin
Drug: vinblastine

Phase 2

Seagen
Seagen

Cleveland, Ohio, United States and 75 other locations

The purpose of this trial is to measure the following in participants with relapsed and/or refractory B-cell lymphoma who receive epcoritama...

Active, not recruiting
Small Lymphocytic Lymphoma (SLL)
Marginal Zone Lymphoma (MZL)
Biological: Epcoritamab

Phase 1, Phase 2

Genmab
Genmab

Cleveland, Ohio, United States and 84 other locations

(firi-cel), a CD22-directed autologous Chimeric Antigen Receptor (CAR) T-cell therapy for the treatment of relapsed or refractory large B-cell lymphoma...

Enrolling
Relapsed/Refractory Large B-cell Lymphoma (LBCL)
Cancer
Drug: Fludarabine (Conditional therapy)
Drug: firi-cel (Experimental drug)

Phase 2

CARGO Therapeutics

Cleveland, Ohio, United States and 29 other locations

plus venetoclax (AV) versus venetoclax plus obinutuzumab (VO) in previously untreated chronic lymphocytic leukemia or small lymphocytic lymphoma...

Active, not recruiting
Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Drug: Obinutuzumab
Drug: Venetoclax

Phase 3

AstraZeneca
AstraZeneca

Cleveland, Ohio, United States and 40 other locations

ciloleucel, or lisocabtagene maraleucel) for diffuse large B-cell lymphoma that has come back (recurrent) or that does not respond to treatm...

Enrolling
Grade 3b Follicular Lymphoma
Transformed Marg Zone Lymph to Diff Large B-Cell Lymphoma
Drug: Cyclophosphamide
Other: Patient Observation

Phase 2

SWOG Cancer Research Network

Cleveland, Ohio, United States and 63 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems